These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 2208545)

  • 1. The importance of calcium ions for in vitro malignant hyperthermia testing.
    Fletcher JE; Huggins FJ; Rosenberg H
    Can J Anaesth; 1990 Sep; 37(6):695-8. PubMed ID: 2208545
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of droperidol, haloperidol and ketamine on halothane, succinylcholine and caffeine contractures: implications for malignant hyperthermia.
    Fletcher JE; Rosenberg H; Lizzo FH
    Acta Anaesthesiol Scand; 1989 Apr; 33(3):187-92. PubMed ID: 2728821
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BAY K 8644 and nifedipine alter halothane but not caffeine contractures of malignant hyperthermic muscle fibers.
    Williams JH; Holland M; Lee JC; Ward CW; McGrath CJ
    Am J Physiol; 1991 Oct; 261(4 Pt 2):R782-6. PubMed ID: 1718170
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of calcium-free solution, calcium antagonists, and the calcium agonist BAY K 8644 on mechanical responses of skeletal muscle from patients susceptible to malignant hyperthermia.
    Adnet PJ; Krivosic-Horber RM; Adamantidis MM; Reyford H; Cordonnier C; Haudecoeur G
    Anesthesiology; 1991 Sep; 75(3):413-9. PubMed ID: 1716078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Porcine malignant hyperthermia: effects of temperature and extracellular calcium concentration on halothane-induced contracture of susceptible skeletal muscle.
    Nelson TE; Bedell DM; Jones EW
    Anesthesiology; 1975 Mar; 42(3):301-6. PubMed ID: 1115384
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 3,5-Di-t-butyl catechol is a potent human ryanodine receptor 1 activator, not suitable for the diagnosis of malignant hyperthermia susceptibility.
    Lacava C; Michalek-Sauberer A; Kraft B; Sgaragli G; Sipos E; Höller C; Kress HG; Fusi F; Weigl LG
    Pharmacol Res; 2012 Jul; 66(1):80-7. PubMed ID: 22480578
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Na(+)-Ca2+ exchange influences halothane and caffeine contractures of malignant hyperthermic skeletal muscle.
    Williams JH; Lee JC; Holland M
    Res Commun Chem Pathol Pharmacol; 1992 Aug; 77(2):253-6. PubMed ID: 1439194
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Porcine malignant hyperthermia: effect of dantrolene sodium on in-vitro halothane-induced contraction of susceptible muscle.
    Anderson IL; Jones EW
    Anesthesiology; 1976 Jan; 44(1):57-61. PubMed ID: 1244776
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro interaction between halothane and succinylcholine in human skeletal muscle: implications for malignant hyperthermia and masseter muscle rigidity.
    Fletcher JE; Rosenberg H
    Anesthesiology; 1985 Aug; 63(2):190-4. PubMed ID: 4025868
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Masseter spasm induced by succinylcholine in children: contracture testing for malignant hyperthermia: report of six cases.
    Flewellen EH; Nelson TE
    Can Anaesth Soc J; 1982 Jan; 29(1):42-9. PubMed ID: 7055743
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro muscle contractures induced by halothane and suxamethonium. II: Human skeletal muscle from normal and malignant hyperthermia susceptible patients.
    Fletcher JE; Rosenberg H
    Br J Anaesth; 1986 Dec; 58(12):1433-9. PubMed ID: 3790395
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro contracture testing for determination of susceptibility to malignant hyperthermia: a methodologic update.
    Iaizzo PA; Wedel DJ; Gallagher WJ
    Mayo Clin Proc; 1991 Oct; 66(10):998-1004. PubMed ID: 1833602
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of the calcium antagonist, TMB-8 on halothane and on caffeine contractures of malignant hyperthermia susceptible skeletal muscle.
    Williams JH; Holland M; Lee JC
    Res Commun Chem Pathol Pharmacol; 1990 Jun; 68(3):387-90. PubMed ID: 2385762
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diltiazem and nifedipine reduce the in vitro contracture response to halothane in malignant hyperthermia-susceptible muscle.
    Adnet PJ; Krivosic-Horber RM; Haudecoeur G; Reyford HG; Adamantidis MM; Dupuis BA
    Can J Anaesth; 1990 Jul; 37(5):556-9. PubMed ID: 2372858
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of benzamil on in vitro contracture responses of human skeletal muscle to halothane.
    Hopkins PM; Ellis FR; Halsall PJ
    Gen Pharmacol; 1994 Jan; 25(1):23-9. PubMed ID: 8026710
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biochemical basis of malignant hyperpyrexia.
    Moulds RF; Denborough MA
    Br Med J; 1974 May; 2(5913):241-4. PubMed ID: 4827070
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Propofol is a 'safe' anaesthetic agent in malignant hyperthermia susceptible patients.
    McKenzie AJ; Couchman KG; Pollock N
    Anaesth Intensive Care; 1992 May; 20(2):165-8. PubMed ID: 1595850
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Caffeine- or halothane-induced contractures of masseter muscle are similar to those of vastus muscle in normal humans.
    Melton AT; Antognini JF; Gronert GA
    Acta Anaesthesiol Scand; 1999 Aug; 43(7):764-9. PubMed ID: 10456818
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diltiazem inhibits halothane-induced contractions in malignant hyperthermia-susceptible muscles in vitro.
    Ilias WK; Williams CH; Fulfer RT; Dozier SE
    Br J Anaesth; 1985 Oct; 57(10):994-6. PubMed ID: 4041327
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sources of variability in halothane and caffeine contracture tests for susceptibility to malignant hyperthermia.
    Ording H; Bendixen D
    Eur J Anaesthesiol; 1992 Sep; 9(5):367-76. PubMed ID: 1396623
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.